{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:11Z","timestamp":1787496971012,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.014","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:30:57Z","timestamp":1681407057000},"page":"3137-3140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh"],"prefix":"10.1016","volume":"41","author":[{"given":"Farhana","family":"Khanam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golap","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazmul Hasan","family":"Rajib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams Uddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ismail","family":"Hossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta Kumar","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Thesis-Nyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yama","family":"Mujadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-9888","authenticated-orcid":false,"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.014_b0005","unstructured":"Global Burden of Disease Collaborative Network. GBD 2019 Cause and Risk Summaries: Typhoid fever \u2014 Level 4 cause. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. http:\/\/wwwhealthdataorg\/results\/gbd_summaries\/2019."},{"key":"10.1016\/j.vaccine.2023.04.014_b0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.04.014_b0015","first-page":"9","article-title":"Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins","author":"Klemm","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2023.04.014_b0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S1473-3099(18)30483-3","article-title":"Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study","volume":"18","author":"Qamar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.014_b0025","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2023.04.014_b0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - Recommendations","volume":"37","author":"World Health O","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.014_b0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.04.014_b0040","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.014_b0045","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.014_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijid.2020.10.103","article-title":"Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","volume":"102","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.014_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2023.04.014_b0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.014_b0065","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/CVI.00245-09","article-title":"Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu","volume":"16","author":"Pulickal","year":"2009","journal-title":"Nepal Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2023.04.014_b0070","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","article-title":"IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model","volume":"10","author":"Dahora","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.04.014_b0075","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:41Z","timestamp":1759404341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23003973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":15,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23003973"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}